A study evaluating SLC19A1 genetic variations on the therapeutic response to MTX in RA patient, based in the role of reduced folate carrier protein (SLC19A1-gene) in the uptake and intracellular accumulation of folates. The gene discussed is SLC19A1; the disease is rheumatoid arthritis.